Vav1-dependent Rac1 activation mediates hypoxia-induced gemcitabine resistance in pancreatic ductal adenocarcinoma cells through upregulation of HIF-1α expression

被引:2
作者
Zhu, Congyuan [1 ,2 ]
Hu, Hao [3 ]
Ma, Ye
Xiong, Shuming [3 ]
Zhu, Dongming [1 ]
机构
[1] Soochow Univ, Dept Gen Surg, Affiliated Hosp 5, Suzhou 215006, Jiangsu, Peoples R China
[2] Jiangnan Univ, Affiliated Hosp, Dept Gen Surg, Wuxi, Peoples R China
[3] Jiangnan Univ, Affiliated Hosp, Dept Hepatobiliary & Pancreat Surg, Wuxi, Peoples R China
关键词
apoptosis; drug resistance; hypoxia; pancreatic ductal adenocarcinoma; Rac1; Vav1;
D O I
10.1002/cbin.12074
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Hypoxia has been shown to induce gemcitabine (GEM) resistance in pancreatic ductal adenocarcinoma (PDAC) cells, however, the underlying mechanisms remain to be clarified. In the present study, we investigated whether activation of Vav1/Rac1/HIF-1 & alpha; axis is responsible for hypoxia-induced GEM resistance in PDAC cells. Our results showed that Rac1 activation contributed to hypoxia-induced GEM resistance in PANC-1 cells. Hypoxia treatment led to an increased expression level of Vav1, which was responsible for Rac1 activation and GEM resistance in PDAC cells. Furthermore, Rac1 mediated hypoxia-induced GEM resistance by upregulating HIF-1 & alpha; in PDAC cells. Taken together, these findings suggest that hypoxia induces GEM resistance in PDAC cells by activating the Vav1/Rac1/HIF-1 & alpha; signaling pathway.
引用
收藏
页码:1835 / 1842
页数:8
相关论文
共 30 条
[1]   Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma [J].
Ahmad, Iman M. ;
Dafferner, Alicia J. ;
O'Connell, Kelly A. ;
Mehla, Kamiya ;
Britigan, Bradley E. ;
Hollingsworth, Michael A. ;
Abdalla, Maher Y. .
CANCERS, 2021, 13 (09)
[2]   Platelet Rho GTPase regulation in physiology and disease [J].
Aslan, Joseph E. .
PLATELETS, 2019, 30 (01) :17-22
[3]   Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma [J].
Chen, Dongjie ;
Huang, Hui ;
Zang, Longjun ;
Gao, Wenzhe ;
Zhu, Hongwei ;
Yu, Xiao .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[4]  
Croise Pauline, 2017, Small GTPases, V8, P122, DOI [10.1080/21541248.2016.1202634, 10.1080/21541248.2016.1202634]
[5]   Reciprocal Regulation of Rac1 and PAK-1 by HIF-1α: A Positive-Feedback Loop Promoting Pulmonary Vascular Remodeling [J].
Diebold, Isabel ;
Petry, Andreas ;
Djordjevic, Talija ;
BelAiba, Rachida S. ;
Fineman, Jeffrey ;
Black, Stephen ;
Schreiber, Christian ;
Fratz, Sohrab ;
Hess, John ;
Kietzmann, Thomas ;
Goerlach, Agnes .
ANTIOXIDANTS & REDOX SIGNALING, 2010, 13 (04) :399-412
[6]   Role of Phytochemicals in Perturbation of Redox Homeostasis in Cancer [J].
Gaikwad, Shreyas ;
Srivastava, Sanjay K. .
ANTIOXIDANTS, 2021, 10 (01) :1-26
[7]   Rac1 repression reverses chemoresistance by targeting tumor metabolism [J].
Ganapathy-Kanniappan, Shanmugasundaram .
CANCER BIOLOGY & THERAPY, 2020, 21 (10) :888-890
[8]   Temporal Rac1-HIF-1 crosstalk modulates hypoxic survival of aged neurons [J].
Guntert, Tanja ;
Gassmann, Max ;
Ogunshola, Omolara O. .
BRAIN RESEARCH, 2016, 1642 :298-307
[9]   ARHGAP25 Inhibits Pancreatic Adenocarcinoma Growth by Suppressing Glycolysis via AKT/mTOR Pathway [J].
Huang, Wen-Kuan ;
Chen, Yi ;
Su, Huafang ;
Chen, Tung-Ying ;
Gao, Jiwei ;
Liu, Yaxuan ;
Yeh, Chun-Nan ;
Li, Shuijie .
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (07) :1808-1820
[10]   Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities [J].
Jain, Aditi ;
Bhardwaj, Vikas .
WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (39) :6527-6550